Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015–2018 Years

BACKGROUND: In Poland drug programmes developed by the Minister of Health and financed by the National Health Fund are special reimbursement frameworks of innovative, expensive, and mostly hospital based medical products used for a small number of patients. RESEARCH DESIGN: The research presented in...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Front Pharmacol
Κύριοι συγγραφείς: Mela, Aneta, Poniatowski, Łukasz A., Drop, Bartłomiej, Furtak-Niczyporuk, Marzena, Jaroszyński, Janusz, Wrona, Witold, Staniszewska, Anna, Dąbrowski, Jan, Czajka, Anna, Jagielska, Beata, Wojciechowska, Monika, Niewada, Maciej
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Frontiers Media S.A. 2020
Θέματα:
Pharmacology
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7456857/
https://ncbi.nlm.nih.gov/pubmed/32922285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01123
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια